Candida albicans biofilm formation is associated with increased anti-oxidative capacities

Proteomics

Volumn 8, Issue 14, 2008, Pages 2936-2947

  Seneviratne, C Jayampath ^a   Wang, Yu ^a   Jin, Lijian ^a   Abiko, Yoshi ^b   Samaranayake, Lakshman P ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NIHON UNIVERSITY   (Japan)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

2 DE; Anti oxidant activity; Biofilm; Biomarker; Candida

Indexed keywords

ALKYL HYDROPEROXIDE REDUCTASE; ECHINOCANDIN; LUCIGENIN; PEROXIDE; THIOREDOXIN; THIOREDOXIN PEROXIDASE;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CHEMOLUMINESCENCE; CONTROLLED STUDY; NONHUMAN; OXIDATIVE STRESS; PLANKTON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

AMINO ACID SEQUENCE; ANTIFUNGAL AGENTS; ANTIOXIDANTS; BIOFILMS; BIOLOGICAL MARKERS; CANDIDA ALBICANS; CANDIDIASIS; DRUG RESISTANCE, FUNGAL; FUNGAL PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; TANDEM MASS SPECTROMETRY;

CANDIDA; CANDIDA ALBICANS;

EID: 48949100522     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200701097     Document Type: Article

References (49)

1. Samaranayake, L. P., MacFarlane, T. W., Oral Candidosis 1990, Wright-Butterworth, London, UK.
2. Becksague, C. M., Jarvis, W. R., Secular trends in the epidemiology of nosocomial fungal-infections in the United States, 1980-1990. J. Infect. Dis. 1993, 167, 1247-1251.
3. Wenzel, R. P., Gennings, C., Bloodstream infections due to Candida species in the intensive care unit: Identifying especially high-risk patients to determine prevention strategies. Clin. Infect. Dis. 2005, 41, S389-S393.
4. Zaoutis, T. E., Argon, J., Chu, J., Berlin, J. A. et al., The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin. Infect. Dis. 2005, 41, 1232-1239.
5. Richardson, M. D., Changing patterns and trends in systemic fungal infections. J. Antimicrob. Chemother. 2005, 56, 5-11.
6. Potera, C., Microbiology - Forging a link between biofilms and disease. Science 1999, 283, 1837-1839.
7. Costerton, J. W., Lewandowski, Z., Caldwell, D. E., Korber, D. R. et al., Microbial Biofilms. Ann. Rev. Microbiol. 1995, 49, 711-745.
8. Donlan, R. M., Costerton, J. W., Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 2002, 15, 167-193.
9. Ramage, G., Martinez, J. P., Lopez-Ribot, J. L., Candida biofilms on implanted biomaterials: A clinically significant problem. FEMS Yeast Res. 2006, 6, 979-986.
10. Hawser, S. P., Douglas, L. J., Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 1995, 39, 2128-2131.
11. Ramage, G., Saville, S. P., Thomas, D. P., Lopez-Ribot, J. L., Candida biofilms: An update. Eukaryot. Cell 2005, 4, 633-638.
12. Jin, Y., Samaranayake, L. P., Samaranayake, Y., Yip, H. K., Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch. Oral Biol. 2004, 49, 789-798.
13. Thein, Z. M., Samaranayake, Y. H., Samaranayake, L. P., Effect of oral bacteria on growth and survival of Candida albicans biofilms. Arch. Oral Biol. 2006, 51, 672-680.
14. Jin, Y., Yip, H. K., Samaranayake, Y. H., Yau, J. Y. et al., Biofilm-forming a ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J. Clin. Microbiol. 2003, 41, 2961-2967.
15. Jin, Y., Zhang, T., Samaranayake, Y. H., Fang, H. H. et al., The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms. Mycopathologia 2005, 159, 353-360.
16. Hansen, S. K., Rainey, P. B., Haagensen, J. A., Molin, S., Evolution of species interactions in a biofilm community. Nature 2007, 445, 533-536.
17. Heydorn, A., Nielsen, A. T., Hentzer, M., Sternberg, C. et al., Quantification of biofilm structures by the novel computer program COMSTAT. Microbiology 2000, 146, 2395-2407.
18. Samaranayake, Y. H., Dassanayake, R. S., Jayatilake, J. A. M. S., Cheung, B. P. K. et al., Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection. J. Med. Microbiol. 2005, 54, 583-593.
19. Vediyappan, G., Chaffin, W. L., Non-glucan attached proteins of Candida albicans biofilm formed on various surfaces. Mycopathologia 2006, 161, 3-10.
20. Wang, Y., Xu, L.Y., Lam, K. S. L., Lu, G. et al., Proteomic characterization of human serum proteins associated with the fat-derived hormone adiponectin. Proteomics 2006, 6, 3862-3870.
21. Yan, J. X., Wait, R., Berkelman, T., Harry,R.A. et al., A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21, 3666-3672.
22. Wang, Y., Lam, K. S., Lam, J. B., Lam, M. C. et al., Overexpression of angiopoietin-like protein 4 alters mitochondria activities and modulates methionine metabolic cycle in the liver tissues of db/db diabetic mice. Mol. Endocrinol. 2007, 21, 972-986.
23. Fernandez-Arenas, E., Cabezon, V., Bermejo, C., Arroyo, J. et al., Integrated proteomics and genomics strategies bring new insight into Candida albicans response upon macrophage interaction. Mol. Cell. Proteomics 2007, 6, 460-478.
24. Schroter, C., Hipler, U. C., Wilmer, A., Kunkel, W. et al., Generation of reactive oxygen species by Candida albicans in relation to morphogenesis. Arch. Dermatol. Res. 2000, 292, 260-264.
25. Baillie, G. S., Douglas, L. J., Role of dimorphism in the development of Candida albicans biofilms. J. Med. Microbiol. 1999, 48, 671-679.
26. Chandra, J., Kuhn, D. M., Mukherjee, P. K., Hoyer, L. L. et al., Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. J. Bacteriol. 2001, 183, 5385-5394.
27. Parahitiyawa, N. B., Samaranayake, Y. H., Samaranayake, L. P., Ye, J. et al., Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. APMIS 2006, 114, 298-306.
28. Hernandez, R., Nombela, C., Diez-Orejas, R., Gil, C., Two-dimensional reference map of Candida albicans hyphal forms. Proteomics 2004, 4, 374-382.
29. Ramage, G., VandeWalle, K., Lopez-Ribot, J. L., Wickes, B. L., The filamentation pathway controlled by the Efg1 regulator protein is required for normal biofilm formation and development in Candida albicans. FEMS Microbiol. Lett. 2002, 214, 95-100.
30. Nobile, C. J., Mitchell, A. P., Genetics and genomics of Candida albicans biofilm formation. Cell. Microbiol. 2006, 8, 1382-1391.
31. Richard, M. L., Nobile, C. J., Bruno, V. M., Mitchell, A. P., Candida albicans biofilm-defective mutants. Eukaryot. Cell 2005, 4, 1493-1502.
32. Bachmann, S. P., VandeWalle, K., Ramage, G., Patterson, T. F. et al., In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob. Agents Chemother. 2002, 46, 3591-3596.
33. Kuhn, D. M., George, T., Chandra, J., Mukherjee, P. K. et al., Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 2002, 46, 1773-1780.
34. Mukherjee, P. K., Mohamed, S., Chandra, J., Kuhn, D. et al., Alcohol dehydrogenase restricts the ability of the pathogen Candida albicans to form a biofilm on catheter surfaces through an ethanol-based mechanism. Infect. Immun. 2006, 74, 3804-3816.
35. Thomas, D. P., Bachmann, S. P., Lopez-Ribot, J. L., Proteomics for the analysis of the Candida albicans biofilm lifestyle. Proteomics 2006, 6, 5795-5804.
36. Garcia-Sanchez, S., Aubert, S., Iraqui, I., Janbon, G. et al., Candida albicans biofilms: A developmental state associated with specific and stable gene expression patterns. Eukaryot. Cell 2004, 3, 536-545.
37. Murillo, L. A., Newport, G., Lan, C. Y., Habelitz, S. et al., Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans. Eukaryot. Cell 2005, 4, 1562-1573.
38. Gonzalez-Parraga, P., Hernandez, J. A., Arguelles, J. C., Role of antioxidant enzymatic defences against oxidative stress (H2O2) and the acquisition of oxidative tolerance in Candida albicans. Yeast 2003, 20, 1161-1169.
39. Chae, H. Z., Chung, S. J., Rhee, S. G., Thioredoxin-Dependent Peroxide Reductase from Yeast. J. Biol. Chem. 1994, 269, 27670-27678.
40. Jean, D., Briolat, V., Reysset, G., Oxidative stress response in Clostridium perfringens. Microbiol.-Sgm 2004, 150, 1649-1659.
41. Nombela, C., Gil, C., Chaffin, W. L., Nonconventional protein secretion in yeast. Trends Microbiol. 2006, 14, 15-21.
42. Albesa, I., Becerra, M. C., Battan, P. C., Paez, P. L., Oxidative stress involved in the antibacterial action of different antibiotics. Biochem. Biophys. Res. Commun. 2004, 317, 605-609.
43. Battan, P. C., Barnes, A. I., Albesa, I., Resistance to oxidative stress caused by ceftazidime and piperacillin in a biofilm of Pseudomonas. Luminescence 2004, 19, 265-270.
44. Hassett, D. J., Ma, J. F., Elkins, J. G., McDermott, T. R. et al., Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol. Microbiol. 1999, 34, 1082-1093.
45. Alvarez-Peral, F. J., Zaragoza, O., Pedreno, Y., Arguelles, J. C., Protective role of trehalose during severe oxidative stress caused by hydrogen peroxide and the adaptive oxidative stress response in Candida albicans. Microbiology 2002, 148, 2599-2606.
46. Jamieson, D. J., Stephen, D. W., Terriere, E. C., Analysis of the adaptive oxidative stress response of Candida albicans. FEMS Microbiol. Lett. 1996, 138, 83-88.
47. Westwater, C., Balish, E., Schofield, D. A., Candida albicans-conditioned medium protects yeast cells from oxidative stress: A possible link between quorum sensing and oxidative stress resistance. Eukaryot. Cell 2005, 4, 1654-1661.
48. Wang, Y., Cao, Y. Y., Jia, X. M., Cao, Y. B. et al., Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. Free Radic. Biol. Med. 2006, 40, 1201-1209.
49. Rogers, P. D., Barker, K. S., Evaluation of differential gene expression in fluconazole-susceptible and -resistant isolates of Candida albicans by cDNA microarray analysis. Antimicrob. Agents Chemother. 2002, 46, 3412-3417.